We demonstrated that IGF2BP1 modulates MYCN expression in neuroblastoma cell models [14, 54], but the underlying mechanisms and potential synergy of both in promoting HRN remained elusive. The gene discussed is IGF2BP1; the disease is neuroblastoma.